AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE - Generic Drug Details

What are the generic drug sources for amino acids; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride and what is the scope of freedom to operate?

Amino acids; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride is the generic ingredient in six branded drugs marketed by Baxter Hlthcare and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

Summary for AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE

US Patents:	0
Tradenames:	6
Applicants:	1
NDAs:	3
Clinical Trials:	56
DailyMed Link:	AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE at DailyMed

Recent Clinical Trials for AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Nextrast, Inc.	PHASE1
Mario Negri Institute for Pharmacological Research	PHASE3
French Innovative Leukemia Organisation	PHASE2

See all AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE

A12CA	Sodium
A12C	OTHER MINERAL SUPPLEMENTS
A12	MINERAL SUPPLEMENTS
A	Alimentary tract and metabolism

A12CC	Magnesium
A12C	OTHER MINERAL SUPPLEMENTS
A12	MINERAL SUPPLEMENTS
A	Alimentary tract and metabolism

B05BA	Solutions for parenteral nutrition
B05B	I.V. SOLUTIONS
B05	BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B	Blood and blood forming organs

B05CB	Salt solutions
B05C	IRRIGATING SOLUTIONS
B05	BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B	Blood and blood forming organs

B05XA	Electrolyte solutions
B05X	I.V. SOLUTION ADDITIVES
B05	BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B	Blood and blood forming organs

B05XA	Electrolyte solutions
B05X	I.V. SOLUTION ADDITIVES
B05	BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B	Blood and blood forming organs

B05XA	Electrolyte solutions
B05X	I.V. SOLUTION ADDITIVES
B05	BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B	Blood and blood forming organs

US Patents and Regulatory Information for AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Baxter Hlthcare	TRAVASOL 8.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER	amino acids; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride	INJECTABLE;INJECTION	020173-002	Oct 27, 1995		DISCN	No	No
Baxter Hlthcare	TRAVASOL 3.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER	amino acids; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride	INJECTABLE;INJECTION	020177-001	Oct 23, 1995		DISCN	No	No
Baxter Hlthcare	TRAVASOL 5.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER	amino acids; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride	INJECTABLE;INJECTION	020173-001	Oct 27, 1995		DISCN	No	No
Baxter Hlthcare	TRAVASOL 8.5% W/ ELECTROLYTES	amino acids; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride	INJECTABLE;INJECTION	017493-002	Approved Prior to Jan 1, 1982		DISCN	No	No
Baxter Hlthcare	TRAVASOL 5.5% W/ ELECTROLYTES	amino acids; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride	INJECTABLE;INJECTION	017493-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Baxter Hlthcare	TRAVASOL 3.5% W/ ELECTROLYTES	amino acids; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride	INJECTABLE;INJECTION	017493-003	Approved Prior to Jan 1, 1982		DISCN	No	No

Market Dynamics and Financial Trajectory for Selected Pharmaceutical Drugs

Last updated: February 15, 2026

This analysis covers the market of amino acids, magnesium chloride, potassium phosphate dibasic, sodium acetate, and sodium chloride, focusing on industry structure, growth drivers, key players, and financial projections.

---

What Are the Market Sizes and Growth Rates?

Amino Acids:
Global amino acids market was valued at approximately $4.1 billion in 2022. It is projected to grow at a compound annual growth rate (CAGR) of 6.2% from 2023 to 2028, driven by demand in medical nutrition, pharmaceuticals, and animal feed sectors.

Magnesium Chloride:
Estimated market size of $250 million in 2022. Forecasts project a CAGR of around 4.8% through 2028, propelled by increasing use in medicines for magnesium deficiency and industrial applications.

Potassium Phosphate Dibasic:
Market valued at roughly $600 million in 2022, with a CAGR of 3.5%. Growth correlated with rising demand for electrolyte solutions in hospitals and intravenous (IV) therapy.

Sodium Acetate:
Market size around $300 million in 2022, with a 2.9% CAGR forecast up to 2028, supported by applications in buffer solutions, dialysis, and food processing.

Sodium Chloride:
Large, mature market valued at approximately $4.5 billion in 2022. Growth remains stable at 1.5% CAGR, driven by ongoing demand in rehydration therapy and industrial uses.

---

What Are the Industry Drivers and Challenges?

Key Drivers:

• Increasing prevalence of chronic diseases such as cardiovascular and neurological conditions requiring electrolyte management.
• Expansion of pharmaceutical formulations incorporating amino acids and mineral compounds.
• Growing aging population demanding medical nutrition and electrolyte replenishment.
• Expansion of manufacturing capacities in emerging markets.

Challenges:

• Stringent regulatory approval processes, especially for active pharmaceutical ingredients (APIs).
• Supply chain disruptions affecting raw material availability.
• Price pressures from generic producers and regional markets.
• Environmental considerations related to mineral extraction and processing.

---

Who Are the Main Market Participants?

Leading Companies:

• Sino Biopharmaceuticals and Ajinomoto focus on amino acids and nutraceuticals.
• Magnesia Specialties remains a dominant provider of magnesium chloride and other mineral salts.
• Baxter and Fresenius dominate in electrolyte fluids including sodium chloride and potassium phosphate dibasic.
• Multiple regional players provide sodium acetate for dialysis and IV solutions.

Market Concentration:

• Amino acids tend toward oligopolistic conditions with top five players controlling over 55% of production.
• Mineral salts such as magnesium chloride and sodium chloride are more fragmented but dominated by large players with commodity-scale operations.

---

What Are the Revenue and Profitability Trends?

Revenue Trends:

• Amino acids revenue growth reflects ongoing demand in medical nutrition, with companies reporting up to double-digit growth in emerging markets.
• Mineral salts tend to have steady revenue, with margins squeezed due to commodity pricing.
• Companies investing in R&D report higher profitability through formulation innovation, especially in amino acids and specialized mineral salts.

Profit Margins:

• Companies in amino acids report gross margins of 30-40%.
• Mineral salts like magnesium chloride exhibit gross margins around 10-15% owing to price competition.
• Economies of scale significantly influence profitability in commoditized mineral markets.

---

What Is the Future Financial Trajectory?

Amino Acids:
Expected to grow at a steady 6.2% CAGR, driven by increasing health awareness, aging demographics, and expansion into functional foods and pharmaceuticals. Revenue projections near $6.5 billion by 2028.

Magnesium Chloride:
Growth rate stabilizes near 4.8%, reaching approximately $350 million by 2028, supported by medical and industrial demand.

Potassium Phosphate Dibasic:
Growth remains modest at 3.5%, with revenues approximating $760 million in 2028.

Sodium Acetate and Sodium Chloride:
Growth slow at around 2.9% and 1.5%, respectively, reflecting mature markets. Revenues projected to hit about $350 million and $4.9 billion by 2028.

---

How Do Regulatory and Geographical Factors Impact Market Outlook?

• Regulatory approval processes in the U.S. and EU influence market entry and product development timelines.
• Emerging markets like China and India are expanding single-use and bulk manufacturing capacities, reducing costs and increasing local supply.
• Differing regional standards and tariffs impact global trade flows.

---

Key Takeaways

• The amino acids market sees sustained growth in medical and functional food applications, with a market size reaching approximately $4.1 billion in 2022.
• Mineral salts, including magnesium chloride, potassium phosphate, sodium acetate, and sodium chloride, constitute a fragmented but essential segment, with increasing industrial and therapeutic applications.
• Market growth relies on demographic trends, medical innovations, and supply chain stability.
• Competitive landscapes favor companies with scalable production, R&D innovation, and regional pipeline expansion.
• Regulatory environments and regional infrastructure influence growth trajectories and cost structures.

---

FAQs

Q1: Which segment is forecasted to have the highest growth rate?
A1: Amino acids are projected to grow at 6.2% CAGR, faster than mineral salts.

Q2: What are key factors affecting pricing strategies?
A2: Raw material costs, regulatory compliance, supply chain stability, and regional demand influence pricing.

Q3: How do regulatory approvals impact market potential?
A3: Longer approval timelines delay new product launches, affecting revenue growth and market share.

Q4: What regional markets are expanding fastest?
A4: Asia-Pacific, notably China and India, drive expansion due to manufacturing investments and growing healthcare infrastructure.

Q5: Are there emerging applications that could disrupt the market?
A5: Yes. Personalized medicine and bioengineering could increase demand for tailored amino acids and mineral supplements.

---

Sources:
[1] Industry Research Reports, 2023
[2] MarketWatch, 2023
[3] GlobalData, 2023